This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Austria? Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European […]
Source
Which pharmaceutical companies have the most SPCs in Romania? Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It […]
Source
New patent expiration for Nalpropion drug CONTRAVE Read Post »
This chart shows the pharmaceutical companies with the most pellets dosed drugs. For a different perspective, see the most popular […]
Source
Which pharmaceutical companies have the most pellets dosed drugs? Read Post »
Annual Drug Patent Expirations for QLOSI Qlosi is a drug marketed by Orasis Pharms and is included in one NDA. […]
Source
Annual Drug Patent Expirations for TLANDO Tlando is a drug marketed by Verity and is included in one NDA. It […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations […]
Source
Pharmaceutical companies with the most ‘New Combination’ drugs Read Post »